EPC EDGEWELL PERSONAL CARE Co
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1096752 · Fiscal year ends 09/30
Financial factors as of 2026-09-30 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.8%
TTM net income YoY-303.5%
TTM EPS YoY-311.3%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—
Margins
Gross margin41.6%
Operating margin2.1%
Net margin-2.6%
FCF margin-0.5%
EBITDA margin5.3%
Returns
ROE-3.4%
ROA-1.4%
ROIC (approx.)1.3%
Asset turnover0.55x
Leverage & solvency
Liabilities / assets58.5%
Debt / equity0.85x
Current ratio1.82x
Interest coverage0.60x
Cash quality & payout
Operating cash flow / net income-0.96x
Accruals ratio-2.8%
Payout ratio—
Capex / revenue3.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q4*2026-09-30 | 2026Q32026-06-30 | 2026Q22026-03-31 | 2026Q12025-12-31 | 2025Q4*2025-09-30 | 2025Q32025-06-30 | 2025Q22025-03-31 | 2025Q12024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $484.10M | $570.10M | $519.50M | $422.80M | $469.90M | $560.40M | $516.60M | $415.10M |
| Cost of revenue | $274.50M | $327.60M | $302.60M | $261.80M | $281.50M | $310.30M | $279.70M | $242.60M |
| Gross profit | $209.60M | $242.50M | $216.90M | $161.00M | $188.40M | $250.10M | $236.90M | $172.50M |
| R&D expense | $15.50M | $13.30M | $14.90M | $13.80M | $15.40M | $13.50M | $13.40M | $13.40M |
| SG&A expense | $107.20M | $108.30M | $111.00M | $102.40M | $105.50M | $100.70M | $102.80M | $99.60M |
| Operating income | $16.90M | $25.00M | $18.40M | -$18.90M | $7.00M | $45.00M | $49.00M | $9.30M |
| Interest expense | $15.00M | $16.70M | $17.90M | $19.30M | $14.80M | $19.40M | $20.20M | $18.80M |
| Pretax income | $10.20M | $18.00M | $7.90M | -$36.90M | -$9.90M | $28.50M | $31.40M | -$12.70M |
| Income tax | -$500,000 | $5.70M | $3.90M | -$7.70M | -$22.10M | $7.00M | $10.60M | -$2.60M |
| Net income | $10.90M | $13.70M | -$10.60M | -$65.70M | -$30.60M | $29.10M | $29.00M | -$2.10M |
| EBITDA | $35.70M | $36.50M | $30.30M | $2.40M | $30.20M | $56.20M | $59.90M | $31.00M |
| EPS (basic) | — | 0.30 | -0.23 | -1.41 | — | 0.62 | 0.60 | -0.04 |
| EPS (diluted) | — | 0.29 | -0.22 | -1.41 | — | 0.62 | 0.60 | -0.04 |
| Dividends declared per share | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| Weighted avg. shares (diluted) | — | 46.60M | 46.80M | 46.60M | — | 47.00M | 48.20M | 48.70M |
| Balance sheet | ||||||||
| Cash & equivalents | $375.60M | $397.10M | $299.70M | $223.30M | $225.70M | $199.60M | $170.10M | $175.50M |
| Receivables | $132.40M | $119.40M | $185.40M | $154.00M | $137.80M | $153.20M | $178.20M | $120.50M |
| Inventory | $445.40M | $433.00M | $450.10M | $461.20M | $433.80M | $488.40M | $512.20M | $501.60M |
| Current assets | $1.12B | $1.11B | $1.11B | $1.06B | $995.50M | $1.00B | $1.01B | $945.20M |
| PP&E, net | $296.70M | $292.70M | $289.50M | $292.50M | $295.00M | $355.70M | $344.60M | $342.70M |
| Goodwill | $1.13B | $1.13B | $1.13B | $1.14B | $1.14B | $1.34B | $1.33B | $1.33B |
| Intangibles | $799.50M | $806.40M | $813.40M | $821.80M | $828.20M | $929.30M | $930.00M | $934.30M |
| Total assets | $3.55B | $3.54B | $3.53B | $3.77B | $3.76B | $3.79B | $3.77B | $3.70B |
| Current liabilities | $616.00M | $603.60M | $613.80M | $497.50M | $565.50M | $567.40M | $536.30M | $459.00M |
| Long-term debt | $1.25B | $1.25B | $1.24B | $1.52B | $1.38B | $1.37B | $1.43B | $1.44B |
| Total debt | $1.25B | $1.25B | $1.24B | $1.52B | $1.38B | $1.37B | $1.43B | $1.44B |
| Total liabilities | $2.08B | $2.08B | $2.09B | $2.28B | $2.20B | $2.23B | $2.26B | $2.20B |
| Shareholders' equity | $1.47B | $1.46B | $1.45B | $1.49B | $1.55B | $1.57B | $1.51B | $1.50B |
| Net debt | $869.90M | $847.90M | $944.70M | $1.30B | $1.16B | $1.17B | $1.26B | $1.27B |
| Shares outstanding | 46.09M | 46.08M | 46.08M | 46.72M | 46.46M | 46.46M | 47.31M | 48.42M |
| Cash flow statement | ||||||||
| Operating cash flow | $2.50M | $118.70M | $54.30M | -$125.90M | $74.10M | $114.80M | $45.10M | -$115.60M |
| Capital expenditure | $18.40M | $15.60M | $14.00M | $11.60M | $27.60M | $15.50M | $17.10M | $16.80M |
| Free cash flow | -$15.90M | $103.10M | $40.30M | -$137.50M | $46.50M | $99.30M | $28.00M | -$132.40M |
| Investing cash flow | -$11.80M | -$14.10M | $325.00M | -$9.90M | -$27.60M | -$12.30M | -$17.30M | -$15.70M |
| Financing cash flow | -$8.10M | -$7.30M | -$300.80M | $133.40M | -$19.10M | -$83.40M | -$37.40M | $109.90M |
| Depreciation & amortization | $18.80M | $11.50M | $11.90M | $21.30M | $23.20M | $11.20M | $10.90M | $21.70M |
| Stock-based compensation | $4.30M | $5.70M | $5.60M | $3.40M | $5.70M | $6.40M | $6.30M | $6.10M |
| Dividends paid | $6.90M | $7.00M | $7.10M | $7.40M | $6.90M | $7.20M | $7.30M | $7.90M |
| Share buybacks | $0 | $0 | $15.80M | $0 | $0 | $24.50M | $35.40M | $30.30M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.